About Eximis Surgical
Eximis Surgical is a company based in Louisville (United States) founded in 2014 by Donna Ford-Serbu.. Eximis Surgical has raised $40.64 million across 8 funding rounds from investors including Questa Capital, Venture Investors and MedTech Innovator. Eximis Surgical offers products and services including Specimen Removal Device. Eximis Surgical operates in a competitive market with competitors including Olympus, Xenocor, SurgiQuest, ClearCam and Carbon Medical Technology, among others.
- Headquarter Louisville, United States
- Founders Donna Ford-Serbu
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Eximis Surgical, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$40.64 M (USD)
in 8 rounds
-
Latest Funding Round
$15.34 M (USD), Series A
Mar 21, 2023
-
Investors
Questa Capital
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eximis Surgical
Eximis Surgical offers a comprehensive portfolio of products and services, including Specimen Removal Device. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables safe, contained removal of specimens in minimally invasive procedures.
Unlock access to complete
Unlock access to complete
Leadership Team
8 people
Operations Team
1 people
Principal Team
1 people
Senior Team
1 people
Unlock access to complete
Funding Insights of Eximis Surgical
Eximis Surgical has successfully raised a total of $40.64M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $15.34 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series A — $15.3M
-
First Round
First Round
(09 Apr 2015)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Series A - Eximis Surgical | Valuation |
investors |
|
| Feb, 2020 | Amount | Series A - Eximis Surgical | Valuation | Questa Capital | |
| Mar, 2018 | Amount | Series A - Eximis Surgical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Eximis Surgical
Eximis Surgical has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Questa Capital, Venture Investors and MedTech Innovator. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage VC and PE investments are directed across multiple sectors.
|
Founded Year | Domain | Location | |
|
Multiple sectors focused seed & early stage VC firm investing in the US, Europe & Asia
|
Founded Year | Domain | Location | |
|
Acceleration of medical device, digital health, and diagnostic companies is facilitated worldwide.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Eximis Surgical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Eximis Surgical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Eximis Surgical Comparisons
Competitors of Eximis Surgical
Eximis Surgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Olympus, Xenocor, SurgiQuest, ClearCam and Carbon Medical Technology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Manufacturer of imaging and surgical products
|
|
| domain | founded_year | HQ Location |
Laparoscopic imaging systems for surgical applications are provided.
|
|
| domain | founded_year | HQ Location |
Products for minimally invasive surgery are developed and supplied.
|
|
| domain | founded_year | HQ Location |
In-vivo cleaners for laparoscopic cameras are developed by ClearCam.
|
|
| domain | founded_year | HQ Location |
Developer of ultrasound imaging systems and surgical endoscopes
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Eximis Surgical
Frequently Asked Questions about Eximis Surgical
When was Eximis Surgical founded?
Eximis Surgical was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Eximis Surgical located?
Eximis Surgical is headquartered in Louisville, United States. It is registered at Louisville, Kentucky, United States.
Who is the current CEO of Eximis Surgical?
Donna Ford-Serbu is the current CEO of Eximis Surgical. They have also founded this company.
Is Eximis Surgical a funded company?
Eximis Surgical is a funded company, having raised a total of $40.64M across 8 funding rounds to date. The company's 1st funding round was a Series A of $5.15M, raised on Apr 09, 2015.
What does Eximis Surgical do?
Eximis Surgical is a medical device company that designs, manufactures and commercializes devices used in minimally invasive surgery in the areas of site access, tissue excision, and visualization of the surgical site. Their product, X Cor Lap Specimen Removal Platform that uses minimal invasive specimen removal in laparoscopic surgery. XCor device for use in hysterectomies. Founders include Kristin Johnson, William Gregg and Donna Ford-Serbu and Dirk Johnson.
Who are the top competitors of Eximis Surgical?
Eximis Surgical's top competitors include Olympus, Endolumik and New View Surgical.
What products or services does Eximis Surgical offer?
Eximis Surgical offers Specimen Removal Device.
Who are Eximis Surgical's investors?
Eximis Surgical has 3 investors. Key investors include Questa Capital, Venture Investors, and MedTech Innovator.